Literature DB >> 7861131

Localization of glycine neurotransmitter transporter (GLYT2) reveals correlation with the distribution of glycine receptor.

F Jursky1, N Nelson.   

Abstract

We studied by immunocytochemical localization, the glycine neurotransmitter transporter (GLYT2) in mouse brain, using polyclonal antibodies raised against recombinant N-terminus and loop fusion proteins. Western analysis and immunocytochemistry of mouse brain frozen sections revealed caudal-rostral gradient of GLYT2 distribution with massive accumulation in the spinal cord, brainstem, and less in the cerebellum. Immunoreactivity was detected in processes with varicosities but not cell bodies. A correlation was observed between the pattern we obtained and previously reported strychnine binding studies. The results indicate that GLYT2 is involved in the termination of glycine neurotransmission accompanying the glycine receptor at the classic inhibitory system in the hindbrain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7861131     DOI: 10.1046/j.1471-4159.1995.64031026.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  24 in total

1.  Differential effects of ethanol on glycine uptake mediated by the recombinant GLYT1 and GLYT2 glycine transporters.

Authors:  E Núñez; B López-Corcuera; R Martínez-Maza; C Aragón
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

Review 2.  Inhibitory synaptic regulation of motoneurons: a new target of disease mechanisms in amyotrophic lateral sclerosis.

Authors:  Lee J Martin; Qing Chang
Journal:  Mol Neurobiol       Date:  2011-11-10       Impact factor: 5.590

3.  Calpain sensitive regions in the N-terminal cytoplasmic domains of glycine transporters GlyT1A and GlyT1B.

Authors:  Martina Baliova; Frantisek Jursky
Journal:  Neurochem Res       Date:  2005-09       Impact factor: 3.996

Review 4.  Molecular biology of glycinergic neurotransmission.

Authors:  F Zafra; C Aragón; C Giménez
Journal:  Mol Neurobiol       Date:  1997-06       Impact factor: 5.590

5.  Glycine transporter type 2 (GlyT2) inhibitor ameliorates bladder overactivity and nociceptive behavior in rats.

Authors:  Satoru Yoshikawa; Tomohiko Oguchi; Yasuhito Funahashi; William C de Groat; Naoki Yoshimura
Journal:  Eur Urol       Date:  2012-02-01       Impact factor: 20.096

6.  An approach to experimental synaptic pathology using green fluorescent protein-transgenic mice and gene knockout mice to show mitochondrial permeability transition pore-driven excitotoxicity in interneurons and motoneurons.

Authors:  Lee J Martin
Journal:  Toxicol Pathol       Date:  2010-12-14       Impact factor: 1.902

7.  Reversible inhibition of the glycine transporter GlyT2 circumvents acute toxicity while preserving efficacy in the treatment of pain.

Authors:  A Mingorance-Le Meur; P Ghisdal; B Mullier; P De Ron; P Downey; C Van Der Perren; V Declercq; S Cornelis; M Famelart; J Van Asperen; E Jnoff; J P Courade
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

8.  Intra-ventrolateral preoptic nucleus injection of γ-aminobutyric acid induces sedation in rats.

Authors:  Ming Xiong; Jing Li; Da Wang; Ellise Delphin; Jiang Hong Ye
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-06-20

9.  Pharmacological properties of glycine transport in the frog retina.

Authors:  Jorge A Pérez-León; Estuardo López-Vera; Rocío Salceda
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

10.  Frequency-dependent glycinergic inhibition modulates plasticity in hippocampus.

Authors:  Tara Keck; Kyle P Lillis; Yu-Dong Zhou; John A White
Journal:  J Neurosci       Date:  2008-07-16       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.